THE SEARLE COMPANY LIMITED The Searle Company Limited
Corporate briefing 2022
Subsidiaries of Searle
The Searle
Company
Limited
- Searle is 56.32% owned by IBL Group.
- Originally founded in US in 1888 by Gideon D. Searle.
- Incorporated in Pakistan as a Private Limited Company in 1965 as a subsidiary of G.D. Searle & Co., USA.
Listed | 74.1% | 90.6% | 100% | 100% | 100% | 100% | ||||||
IBL | Searle | Searle | Searle | Searle | IBL Future | |||||||
HealthCare | Pakistan | Biosciences | Laboratories | Pharmaceuticals | Technology | |||||||
Limited | Limited | Private Limited | Private Limited | Private Limited | Private Limited | |||||||
87.2%
Nextar
Pharmaceuticals
Private Limited
Our Footprints
E XC E L L E N C E I N C O M M E R C I A L O P E R AT I O N S
No.1
- Cardiovascular
- Pain Management
- Gynae
- Cough Suppressant
- Anaemia
No.2
- Pulmonology
- Neurology and Pediatrics
No.3
- Anti-Infectives
ND
2
- Largest Pharmaceutical Company
In terms of Product Consumptions(Unit)
- Exporter in Pakistan
Everyday
>539,000
Prescriptions are prescribed by Doctors
A Passionate Team of
2,450
Medical Sales Professionals Serving the Nation
1Billion | Billion Rupee Club |
Plus | 6Brands |
500Mn | 500 Million Plus Club |
Plus | |
8 Brands |
CAGR 5 YR
17%
Growing with Double Digit on 5 yr horizon
Achievements
C O M M I T M E N T TO E XC E L L E N C E
Searle was ranked as the most company in Healthcare sector of per Asiamoney's Outstanding Poll, 2018 & 2021.
Searle has been part of Forbes
Under A Billion rankings from 2017
Searle won Asia's Best
Companies 2021, category of Asia
Excellence & Sustainability Awards.
Pharmaceutical Industry
The pharmaceutical sector recorded revenue of PKR 678bn (USD 3.5 bn) in last 12 months with YoY growth of 15.29% (against PKR 588bn in last year).
Market share of Multinational &
National
28.00%
No. of Companies | |||
Multinational | 26 | ||
Multinational | |||
National | 741 | ||
National
72.00%
Market share of Top 100
companies
2.80%
Top 100 companies
Rest 641 companies
97.20%
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Searle Company Ltd. published this content on 08 December 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 December 2022 07:32:05 UTC.
